RACHEL GURRIERI: Open Payments
NPI 1467068171 · BABYLON, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,745 in 124 payments from 22 companies in 2025. Trend: 2023 $828 · 2024 $2,518 · 2025 $2,745
Food & beverage: $2,702Education: $43
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 23 | $585 |
| LEO Pharma Inc. | 12 | $321 |
| Janssen Biotech, Inc. | 11 | $265 |
| Lilly USA, LLC | 16 | $262 |
| Regeneron Healthcare Solutions, Inc. | 8 | $173 |
| Galderma Laboratories, L.P. | 11 | $172 |
| Incyte Corporation | 8 | $158 |
| GENZYME CORPORATION | 4 | $146 |
| Arcutis Biotherapeutics, Inc. | 4 | $143 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 8 | $140 |
Products named: SKYRIZI, ADBRY, DUPIXENT, TREMFYA, RINVOQ, EBGLYSS, OPZELURA, Zoryve.
Industry payments across NY — which companies pay providers there.
